<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02339597</url>
  </required_header>
  <id_info>
    <org_study_id>EA1/306/13</org_study_id>
    <nct_id>NCT02339597</nct_id>
  </id_info>
  <brief_title>Therapy Adherence of APAP Therapy Initiation in Sleep-lab Versus at Home</brief_title>
  <official_title>Therapy Adherence in Different Settings of Automatic Positive Airway Pressure (APAP) Therapy Initiation in Patients With Obstructive Sleep Apnea (OSA): Comparison Between in Sleep-lab vs. at Home Environment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dr. Ingo Fietze</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary hypothesis:

      The objective compliance ( # of hours per night of APAP therapy) is higher in patients who
      get the APAP treatment initiation at home due to the fact that they get better support by
      telemetric control and the possibility of prompt interventions.

      Secondary hypothesis:

      Based on the higher support at the home APAP initiation the following parameters will be
      better in comparison to the standard supply in laboratory:

      Objective measures:

        -  mask leakage

        -  pressure

        -  Apnea-Hypopnea-Index (AHI)

      Subjective measures:

        -  quality of life

        -  sleepiness
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of usage hours of of positive airway pressure therapy per night</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apnea Hypopnea Index [1 / hour of sleep)</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">224</enrollment>
  <condition>Patient Compliance</condition>
  <arm_group>
    <arm_group_label>APAP Lab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>standard Initiation of APAP therapy in sleep laboratory.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>APAP Home</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>initiation of APAP therapy in homely environment with additional continuous telemetric support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Automatic Positive Airway Pressure (APAP) initiation</intervention_name>
    <arm_group_label>APAP Lab</arm_group_label>
    <arm_group_label>APAP Home</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent from patients after verbally and written informing

          -  Age between 18 and 80 Years

          -  obstructive sleep apnea syndrome (OSAS) with an AHI &gt; 15/h and without previous
             therapy

        Exclusion Criteria:

          -  Intolerance to wear the PAP therapy mask

          -  sleep breathing disorders (SBD) with central apneas &gt; 20% and other sleep disorders

          -  disabilities who prevents the wear of a therapy mask

          -  initiated PAP therapy

          -  pre-treatment of OSAS incl. UPPP (uvulo palato pharyngo plasty)

          -  modified Mallampati Score T3 and T4

          -  participation on clinical studies 4 weeks before start of the study

          -  known or acute psychiatric/neurological or psychological disorders, who impairs the
             compliance to take part of the study.

          -  chronical or new clinically significant pneumological or cardiovascular disease
             (exception: effectively therapies of hypertension, cardiac arrhythmia and coronal
             cardiac disease)

          -  acute internistic disease

          -  neuromuscular disease

          -  condition after Apoplexy

          -  oncological disease in recent 5 years

          -  drug/alcohol consumption

          -  consumption of von psychotropic drugs, hypnotics and other drugs who are able to
             influence the sleep/wake cycle
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ingo Fietze, MD, PhD</last_name>
    <phone>+4930450513160</phone>
    <email>ingo.fietze@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charite-Universitaetsmedizin Berlin, Center for Sleep Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingo Fietze, MD, PhD</last_name>
      <phone>+4930450513160</phone>
      <email>ingo.fietze@charite.de</email>
    </contact>
    <investigator>
      <last_name>Ingo Fietze, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2014</study_first_submitted>
  <study_first_submitted_qc>January 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2015</study_first_posted>
  <last_update_submitted>January 12, 2015</last_update_submitted>
  <last_update_submitted_qc>January 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Ingo Fietze</investigator_full_name>
    <investigator_title>Head of Sleep Lab</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

